Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lobe Sciences Ltd
(CSE:
LOBE
)
0.0200
UNCHANGED
Official Closing Price
Updated: 3:25 PM EDT, Sep 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
28,000
Open
0.0200
Bid (Size)
0.0150 (138,000)
Ask (Size)
0.0200 (104,000)
Prev. Close
0.0200
Today's Range
0.0200 - 0.0200
52wk Range
0.0100 - 0.0250
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Lobe Sciences Announces Creation of Wholly Owned Subsidiary, Alera Pharma, Inc.
August 15, 2024
From
Lobe Sciences Ltd
Via
Business Wire
Lobe Sciences Announces Appointment of a New Board of Directors and Executive Management Team
August 12, 2024
From
Lobe Sciences Ltd
Via
Business Wire
Performance
More News
Read More
Lobe Sciences Announces Update
June 04, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Chronic Cluster Headaches No More: The Promise Of Lobe Sciences' At-Home Psychedelic Treatments Without The Trip!
March 01, 2023
Via
TheNewswire.com
Wesley Ramjeet to Join Lobe Sciences’ Board of Directors, Bringing Decades of Strategic Financial Expertise
June 03, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Lobe Sciences Announces Frederick D. Sancilio Ph.D. to Join Board of Directors
May 31, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Former Merck Director and Vanderbilt Vice-Chancellor, Dr. Harry Jacobson, to Join Lobe Sciences Board of Directors
May 30, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Lobe Sciences Ltd. and Clearway Global Announce Change of Control and Focus on Creating Value for Shareholders
May 21, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Lobe Sciences Provides Company Review of 2023
January 08, 2024
From
Lobe Sciences Ltd.
Via
Business Wire
Lobe Sciences Provides Update on L-130 Clinical Program
December 07, 2023
From
Lobe Sciences Ltd.
Via
Business Wire
Lobe Sciences Provides Update on L-130 Oral Psilocin Compound
December 05, 2023
From
Lobe Sciences Ltd.
Via
Business Wire
Lobe Sciences, Ltd. Announces Amendment to the Acquisition of Altemia™ & Company
September 14, 2023
From
Lobe Sciences Ltd.
Via
Business Wire
Lobe Sciences Initiates Phase 1 Clinical Trial of L-130
June 27, 2023
From
Lobe Sciences Ltd.
Via
Business Wire
Lobe Sciences Appoints Baxter Phillips III, MBA as Chief Operating Officer
June 07, 2023
From
Lobe Sciences Ltd.
Via
Business Wire
Lobe Sciences Announces Commercial Distribution Agreement With Pentec Health for US Launch of Altemia™
May 17, 2023
From
Lobe Sciences Ltd.
Via
Business Wire
The Power Play by The Market Herald Releases New Interviews with ARway, Silver Bullet Mines, Galantas Gold, Lobe Sciences, Northstar Gold and Rover Metals Discussing Their Latest News
April 19, 2023
Via
ACCESSWIRE
Psychedelic-Derived Medicines for Neurologic Conditions Fueling Large Revenue Growth in Projected $4 Billion Dollar Industry
January 26, 2023
Via
FinancialNewsMedia
Topics
Economy
Exposures
Supply Chain
Lobe Sciences, Ltd. Enters Collaborative Clinical Research Agreement with Integrative Headache Medicine of New York to Study the Effects of L-130 in the Treatment of Chronic Cluster Headache
January 26, 2023
Via
FinancialNewsMedia
Exposures
Product Safety
Lobe Sciences Ltd (LOBEF) increases its portfolio with several new chemical entities (NCEs)
January 19, 2023
Via
AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
Lobe Sciences Announces Incorporation of Australian Subsidiary
September 23, 2022
Via
Newsfile
Lobe Sciences Announces Closing of Private Placement
September 08, 2022
Via
Newsfile
Lobe Sciences and Cantheon Capital Enter into Exclusive Investment Agreement to Fund $1.5M USD Toward Clinical Trials in Australia
September 01, 2022
Via
Newsfile
Topics
Cannabis
Exposures
Cannabis
Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) Featured in Coverage of Planet MicroCap’s Virtual Investor Conference
April 19, 2022
Via
Investor Brand Network
Lobe Sciences Ltd. (OTCQB: LOBEF) (CSE: LOBE) Featured in Coverage of Investor Summit Group’s Q1 Virtual Event
March 07, 2022
Via
Investor Brand Network
Lobe Sciences to Participate at the Advances in Mental Health Psychedelics and Non-Psychedelics Conference
September 15, 2021
Via
Newsfile
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit